| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 75,782 | 74,851 | 69,195 | 66,167 | | Cost of Revenue | 35,437 | 34,670 | 32,387 | 30,428 | | | Gross Profit | 40,346 | 40,181 | 36,808 | 35,740 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 29,940 | 30,147 | 27,223 | 26,462 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,405 | 10,034 | 9,585 | 9,278 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,732 | 10,034 | 9,585 | 9,278 | | Interest Expense | (517) | 204 | 313 | 414 | | Income Before Tax | 10,249 | 9,830 | 9,272 | 8,864 | | Income Tax Expense | 3,986 | 3,834 | 3,668 | 3,658 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,263 | 5,996 | 5,604 | 5,206 | | | Non-recurring Events | | Discontinued Operations | (97) | (2) | (9) | (10) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,166 | 5,994 | 5,595 | 5,196 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,166 | $5,994 | $5,595 | $5,196 |
|
1.52% Nasdaq 0.00%
Income Statement
